利水明目方联合532激光治疗中心性浆液性脉络膜视网膜病变的临床研究  

Clinical observation of traditional Chinese medicine combined with 532nm laser on central serous chorioretinopathy

在线阅读下载全文

作  者:于彬科[1] 王金平[1] 段灵霞[1] 杨维刚[1] 赵莉[1] 司永练[1] 

机构地区:[1]延安大学咸阳医院(中铁二十局中心医院)眼科,咸阳712000

出  处:《中国中医眼科杂志》2013年第5期332-335,共4页China Journal of Chinese Ophthalmology

摘  要:目的观察利水明目方联合532激光治疗中心性浆液性脉络膜视网膜病变(CSC)的临床效果。方法采用随机数字表法将患者随机分为观察组33例34只眼和激光治疗组34例36只眼、中药组20例21只眼,观察组采用利水明目方联合532 nm激光光凝治疗,激光组采用单纯激光光凝,中药组采用单纯中药治疗,并从最佳矫正视力(bestcorrected visual acuity BCVA)、中心视野(central perimetry)及光学相干断层扫描(optical coherence tomography,OCT)检查黄斑区水肿消退的情况。结果观察组的自觉症状、BCVA改善情况、10°中心视野视敏度改善情况及眼底黄斑区水肿的吸收明显好于单纯激光治疗组及单纯中药组(P<0.05)。结论对中心性浆液性脉络膜视网膜病变应用利水明目方联532激光治疗,疗效明显优于单纯激光光凝及单纯中药组。OBJECTIVE To observe the efficacy of traditional Chinese medicine combined with 532nm photocoagulation on central serous chorioretinopathy (CSC). METHODS All patients were divided into observation group (33 cases, 34 eyes) treated with 532nm photocoagulation combined with traditional Chinese medicine; control group A(34 cases, 36 eyes) treated with 532nm photocoagulation only; and control group B (20 cases, 21 eyes) treated with traditional Chinese medicine only. The results were observed according to best corrected visual acuity (BCVA), mean retinal sensitivity in the central 10 degrees (central perimetry) subsiding of macular edema. RESULTS The vision improving in observation group was higher than that of the control group A and group B, and in observation group the absorbing of macular edema was better than that of the control group. CONCLUSIONS Effect of traditional Chinese medicine combined with 532nm photocoagulation in the treatment of central serous chorioretinopathy was better than that of either 532nm photocoagulation or traditional Chinese medicine only.

关 键 词:532激光 中心性浆液性脉络膜视网膜病变 黄斑水肿 

分 类 号:R774.11[医药卫生—眼科] R779.63[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象